$600.2 M

KURA Mkt cap, 07-Jan-2019
Kura Oncology Net income (Q3, 2018)-15 M
Kura Oncology Cash, 30-Sep-201820.6 M
Kura Oncology EV585.9 M

Kura Oncology Income Statement

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017

R&D expense

13.9m16.6m25.1m

General and administrative expense

22.7k6.0m7.9m9.4m

Operating expense total

22.7k23.9m28.4m36.1m

EBIT

(22.7k)

Interest expense

5.9k42.0k577.0k888.0k

Interest income

128.0k499.0k751.0k

Net Income

(28.6k)(22.6m)(27.6m)(35.4m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

R&D expense

3.3m3.6m3.6m4.0m4.3m5.2m5.2m6.8m11.3m11.1m11.5m

General and administrative expense

4.5k4.1k5.2k1.5m1.8m2.4m1.8m1.7m2.1m2.2m2.3m3.4m3.7m4.3m

Operating expense total

4.5k4.1k5.2k5.9m6.4m7.0m6.8m7.1m7.7m7.9m9.5m15.0m15.3m16.0m

EBIT

(4.5k)(4.1k)(5.2k)

Interest expense

1.7k1.6k1.6k42.0k189.0k194.0k203.0k209.0k226.0k258.0k267.0k252.0k

Interest income

22.0k38.0k114.0k124.0k131.0k128.0k124.0k197.0k450.0k624.0k1.0m

Net Income

(6.1k)(5.8k)(6.9k)(5.6m)(6.1m)(6.6m)(6.7m)(6.9m)(7.5m)(7.8m)(9.3m)(14.6m)(14.7m)(15.0m)

Kura Oncology Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

6.6k5.6k15.4m9.7m11.4m

Accounts Receivable

92.4m

Inventories

693.0k725.0k

Current Assets

86.9m68.8m94.6m

PP&E

71.0k40.0k10.0k

Total Assets

9.1k5.6k87.3m69.8m95.9m

Accounts Payable

350.02.4k4.1m4.7m8.3m

Short-term debt

1.5m

Current Liabilities

5.1m5.5m10.0m

Long-term debt

5.6m

Total Debt

7.1m

Total Liabilities

133.0k5.2m12.9m16.0m

Additional Paid-in Capital

49.5k49.5k108.5m110.7m169.2m

Retained Earnings

(26.3m)(53.9m)(89.3m)

Total Equity

(124.0k)(154.7k)82.1m56.9m79.9m

Debt to Equity Ratio

0.1 x

Debt to Assets Ratio

0.1 x

Financial Leverage

-0.1 x0 x1.1 x1.2 x1.2 x

Kura Oncology Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(28.6k)(30.7k)(22.6m)(27.6m)(35.4m)

Depreciation and Amortization

20.0k31.0k30.0k

Accounts Receivable

Inventories

(42.0k)(32.0k)

Accounts Payable

(1.5k)2.1k2.8m471.0k3.6m

Cash From Operating Activities

(23.2k)(16.0k)(17.9m)(25.3m)(28.4m)

Purchases of PP&E

(64.0k)(64.0k)

Cash From Investing Activities

(70.6m)12.2m(23.4m)

Cash From Financing Activities

25.0k15.0k102.9m7.5m53.6m

Interest Paid

352.0k627.0k

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(5.6m)(66.0k)(6.6m)(6.7m)(6.9m)(7.5m)(9.3m)

Inventories

909.0k

Accounts Payable

650.0713.08.2k10.7k2.5m3.7m3.1m3.3m4.2m3.7m4.2m6.2m

Kura Oncology Ratios

USDY, 2018

Financial Leverage

1.1 x
Report incorrect company information

Kura Oncology Operating Metrics

FY, 2016

Phase II Trials Products

1

Preclinical Phase Products

2
Report incorrect company information

Kura Oncology Employee Rating

00 votes
Culture & Values
N/A
Work/Life Balance
N/A
Senior Management
N/A
Salary & Benefits
N/A
Career Opportunities
N/A
Source